OKYO Pharma Limited - Ordinary Shares - New
OKYO
Get informed when a big investor buys or sells
+ FollowMarket Cap$61M
Close$
$0.04
97.5% downside
Current Fair Value
97.5% downsideOvervalued by 97.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $61.00 Million |
|---|---|
| Enterprise Value | $56.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | 0.02 |
| Outstanding Shares | 37,421,328 |
Return
| Return on Equity | 135.16% |
|---|---|
| Return on Assets | -99.40% |
| Return on Invested Capital | 183.28% |
Valuation & Multiples
| P/E Ratio | -12.9 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | -1.61 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -9.1 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | -0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data